Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

antiemetic/nausée

Le lien est enregistré dans le presse-papiers
Page 1 de 26 résultats

Combinations of amisulpride and another anti-emetic for treating nausea and vomiting

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
RELATED APPLICATIONS This application is a U.S. National Phase application, filed under 35 U.S.C. .sctn. 371(c), of International Application No. PCT/GB2016/050998, filed on Apr. 11, 2016, which claims the benefit of and priority to United Kingdom Patent Application No. 1506116.1, filed on Apr. 10,

Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF INVENTION 1. Field of the Invention The present invention relates to a novel method of administering anti nausea and anti emetic agents and to novel dosage forms containing such agents adapted for nasal administration. The invention provides a novel method of administering therapeutic

Anti-nausea compositions and methods

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to novel nutritional anti-nausea compositions, anti-emetic compositions and methods of using the same to provide relief from nausea and/or vomiting. The present compositions are also nonteratogenic and are

Antiemetic-oral contraceptive combination

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This application is a National Stage Application of PCT/IN2008/000704, filed Oct. 24, 2008, which claims benefit of Serial No. 1460/KOL/2007, filed Oct. 25, 2007 in India and which applications are incorporated herein by reference. To the extent appropriate, a claim of priority is made to each of

Anti-emetic composition

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION The present invention relates to both a therapeutic composition comprising a combination of antiemetic drugs and to a method for treating emesis, including nausea. BACKGROUND OF THE INVENTION Nausea and vomiting can follow the administration of many drugs, particularly

EAA antagonists as anti-emetic drugs

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION This invention is in the field of pharmacology, and relates to anti-emetic drugs, i.e., drugs that suppress nausea and vomiting. BACKGROUND OF THE INVENTION "Emesis" and "emetic" refer to the process commonly known as vomiting or retching, wherein the stomach is evacuated

Use of amisulpride as an anti-emetic

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION This invention relates to the use of amisulpride in the therapy of nausea, vomiting and retching. BACKGROUND OF THE INVENTION Emesis is the act of vomiting and can be described as the forceful expulsion of gastrointestinal contents through the mouth brought about by the

Use of amisulpride as an anti-emetic

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION This invention relates to the use of amisulpride in the therapy of nausea, vomiting and retching. BACKGROUND OF THE INVENTION Emesis is the act of vomiting and can be described as the forceful expulsion of gastrointestinal contents through the mouth brought about by the

Use of amisulpride as an anti-emetic

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION This invention relates to the use of amisulpride in the therapy of nausea, vomiting and retching. BACKGROUND OF THE INVENTION Emesis is the act of vomiting and can be described as the forceful expulsion of gastrointestinal contents through the mouth brought about by the

Use of amisulpride as an anti-emetic

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION This invention relates to the use of amisulpride in the therapy of nausea, vomiting and retching. BACKGROUND OF THE INVENTION Emesis is the act of vomiting and can be described as the forceful expulsion of gastrointestinal contents through the mouth brought about by the

Use of amisulpride as an anti-emetic

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION This invention relates to the use of amisulpride in the therapy of nausea, vomiting and retching. BACKGROUND OF THE INVENTION Emesis is the act of vomiting and can be described as the forceful expulsion of gastrointestinal contents through the mouth brought about by the

Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION This invention is concerned with compounds of structural formula I: ##STR1## wherein X is --CH.dbd.CH--, --CH.sub.2 --CH.sub.2 --, --CH.sub.2 --O--, --O--CH.sub.2 --, --S--CH.sub.2 --, --CH.sub.2 --S--, --S-- or --O--, and R is a 5- or 6-membered nitrogen heterocyclic

Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION This invention is concerned with compounds of structural formula I: ##STR1## wherein X is --CH.dbd.CH--, --CH.sub.2 --CH.sub.2 --, --CH.sub.2 --O--, --O--CH.sub.2 --, --S--CH.sub.2 --, --CH.sub.2 --S--, --S-- or --O--, and R is a 5- or 6-membered nitrogen heterocyclic

Method of treatment of nausea, vomiting, and other disorders using estrogens

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
CROSS-REFERENCE TO RELATED APPLICATIONS Not applicable. STATEMENT REGARDING FEDERALLY SPONSERED RESEARCH OR DEVELOPMENT Not applicable. REFERENCE TO A MICROFICHE APPENDIX Not applicable. BACKGROUND OF THE INVENTION 1. Field of the Invention A new use for estrone, derivatives of estrone, equilin and

Pharmaceutical compositions containing granisetron and dexamethasone

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This invention relates to a method of treatment and/or prophylaxis of nausea and vomiting, comprising the administration of a compound having 5-HT.sub.3 receptor antagonist activity. EP-A-200444 (Beecham Group p.l.c.), Example 6 discloses granisetron, and its use as an anti-emetic, especially useful
Rejoignez notre
page facebook

La base de données d'herbes médicinales la plus complète soutenue par la science

  • Fonctionne en 55 langues
  • Cures à base de plantes soutenues par la science
  • Reconnaissance des herbes par image
  • Carte GPS interactive - étiquetez les herbes sur place (à venir)
  • Lisez les publications scientifiques liées à votre recherche
  • Rechercher les herbes médicinales par leurs effets
  • Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets

Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées

Google Play badgeApp Store badge